This compilation includes all of our research to-date on the coronavirus. High frequency charts on infection, mortality, economic and market data are updated as data becomes available, usually on a daily basis.
What’s new: US economy showing some signs of slowing after COVID surge (Section 1); Tracking the COVID surge in the US and Europe (Section 2); Vaccination update by country and US state (Section 3); Tracking ICU spare capacity by state (Section 2 and Section 5).
Our research to-date on the coronavirus: |
1. US spending, mobility, and production tracker
- High frequency recovery tracking (mobility, manufacturing, retail, air travel, geolocation, oil, hotels, housing, etc.)
- Real time credit and debit spending data
2. COVID global infection, hospitalization and mortality tracker
- Global COVID infection snapshot by US state and country (trends, declines from peak levels)
- US hotspot tracking: infections, hospitalizations, mortality, testing and doctor visits
- Infection and mortality time series by country
- How lethal is COVID, and for whom?
3. COVID vaccination update and drug development
- Preliminary read on Pfizer vaccine efficacy from Israel
- Vaccination update by country and US state
- Vaccine coverage timelines by country for vulnerable and total populations
- How mRNA vaccines, vector vaccines and traditional vaccine types work
- Pfizer, Moderna and Oxford/Astrazeneca Phase III results
- Vaccine production, distribution and acceptance challenges
- The latest news on anti-virals, monoclonal antibodies, convalescent plasma and corticosteroids
4. COVID: testing for the virus and for antibodies, T-cell immune memory and survivor impacts
- How virus testing and antibody testing work
- Pre-existing T-cell immune memory and COVID
- The latest seroprevalence tests in US states
- The issue of falling antibody levels in convalescing patients
- COVID health impacts on survivors
5. Detailed virus reports by state
- One-page reports on each state with charts on infections, hospitalizations, mortality, testing levels, positive test rates, hospital ICU capacity rates and doctor visit indicators
1. The US reopens: tracking US citizens and consumers
- High frequency recovery tracking (mobility, manufacturing, retail, air travel, geolocation, oil, hotels, housing, etc.)
- Real time credit and debit spending data
2. COVID global infection, hospitalization and mortality tracker
- Global COVID infection snapshot (trends, declines from peak levels, threshold levels)
- US hotspot tracking: infections, hospitalizations, mortality, testing and doctor visits
- Infection and mortality time series by country
3. COVID drug development (vaccines, antivirals, mAbs, steroids and blood thinners)
- What we know on the Pfizer/BioNTech vaccine news
- The latest news on anti-virals, vaccines, monoclonal antibodies, convalescent plasma and corticosteroids
- Potential benefits of anticoagulants, statins and ACE inhibitors for infected patients
- The latest news on anti-virals, vaccines, monoclonal antibodies, convalescent plasma and corticosteroids
- Potential benefits of anticoagulants, statins and ACE inhibitors for infected patients
5. COVID: testing for the virus and for antibodies, T-cell immune memory and survivor impacts
- How virus testing and antibody testing work
- Latest regional serology results and implications for higher levels of immunity
- Pre-existing T-cell immune memory and COVID
- The issue of falling antibody levels in convalescing patients
- COVID health impacts on survivors
6. Detailed virus reports by state
- One-page reports on each state with charts on infections, hospitalizations, mortality, testing levels, positive test rates, hospital bed/ICU utilization rates and doctor visit indicators
This compilation incorporates research and feedback from the Johns Hopkins University Center for Health Security, Harvard Medical School, the University of Toronto Dalla Lana School of Public Health, Washington University Biomedical Sciences Department, the La Jolla Institute for Immunology, the Imperial College of London Department of Infectious Disease Epidemiology and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
0903c02a8283f910
